As the tumor-immune crosstalk for HGSOC is still largely uncharted, these results prompted us first to understand whether a higher amount of cytotoxic T lymphocytes could impact patients’ prognosis, subdividing FI-like and OSE-like groups into CD8+ high and low and performing overall survival analysis. Here, CD8A is linked to neoplasm.